Danaher Corp. Stock
€174.98
Your prediction
Danaher Corp. Stock
Pros and Cons of Danaher Corp. in the next few years
Pros
Cons
Performance of Danaher Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Danaher Corp. | 0.740% | 0.977% | 1.734% | -27.032% | -21.045% | -25.833% | 14.533% |
Parker-Hannifin | 0.350% | -3.836% | -5.849% | 20.528% | -7.810% | 132.547% | 248.892% |
W.W. Grainger Inc. | 1.170% | -4.060% | -4.950% | 8.859% | -8.435% | 104.120% | 244.459% |
IDEX Corp. | 0.680% | -4.228% | -9.115% | -16.797% | -22.956% | -10.436% | 13.272% |

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Danaher Corp's current financial position shows:
Key findings: * Revenue remained relatively stable compared to the same quarter last year ($5.741 billion in Q2 2024) * Net profit decreased by 12.3% compared to Q2 2024 ($1.088 billion vs $1.242 billion) * Cash and cash equivalents decreased to $1.993 billion from $2.078 billion at the end of 2024
Overall financial trend: Mixed
Comments
News

It's Unofficially Summer. Time to Get Outside, and Talk With Decking Expert Trex CEO Bryan Fairbanks
In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Bill Mann discuss:
Motley Fool analysts Andy Cross and Sanmeet Deo caught up with Trex CEO Bryan Fairbanks to talk about

3 Stocks Offering Strong Value and Stability
Though not as safe a bet as safe-haven assets like precious metals, value stocks are nonetheless an enticing option for investors when the market gets bumpy. An undervalued company that has

Veralto: Revenue and Earnings Rise in Q4
Veralto (NYSE:VLTO), a key player in water treatment and printing solutions, announced its fourth-quarter earnings on Feb. 4. The company, which was spun off from Danaher in 2023, reported revenue